ASMB · Assembly Biosciences, Inc. · Financials
Market Cap
$606.75M
Shares
20.36M
Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.
Revenue
$72.3M
+153.5%
FY2025
Net Income
-$6.12M
+84.8%
FY2025
Operating Margin
-16.76%
+142.5pp
FY2025
Diluted EPS
-$0.55
+91.8%
FY2025
Operating Cash Flow
-$41.09M
+19.6%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2009 | FY2008 | FY2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $74.85M | $72.3M | $28.52M | $7.16M | $0 | $6.25M | $79.11M | $15.96M | $14.8M | $9.02M | $0 | — | — | — | — | — | — | — | — | — | |
| $63.65M | $64.81M | $55.93M | $48.9M | $69.98M | $68.52M | $106.82M | $85.76M | $72.74M | $44.23M | $33.09M | $18.36M | $10.72M | $15.03M | $19.51M | $25.28M | $1.85M | $2.94M | — | — | |
| $19.99M | $19.61M | $18.01M | $22.91M | $24.13M | $28.78M | $37.06M | $32.92M | $34.8M | $17.02M | $12.19M | $11.3M | $13.24M | $4.58M | $5.34M | $8.72M | $2.92M | $397.24K | — | — | |
| $110K | $129K | $129K | $450K | $498K | $466K | $691K | $494K | $643K | $219K | — | — | — | — | — | — | — | — | — | — | |
| — | — | — | $0 | $1.1M | $1.61M | $3.84M | $2.09M | — | — | — | — | — | — | — | — | — | — | — | — | |
| $83.64M | $84.42M | $73.94M | $71.81M | $94.11M | $138.94M | $143.88M | $118.68M | $107.54M | $61.25M | — | — | — | — | — | — | — | — | — | — | |
| -$8.8M | -$12.12M | -$45.42M | -$64.65M | -$94.11M | -$132.69M | -$64.78M | -$102.71M | -$92.74M | -$52.23M | -$45.28M | -$29.66M | -$23.96M | -$19.6M | -$24.86M | -$34M | -$4.77M | -$3.34M | — | — | |
| — | -16.76% | -159.26% | -902.5% | — | -2121.65% | -81.89% | -643.44% | -626.42% | -579.08% | — | — | — | — | — | — | — | — | — | — | |
| -$8.69M | -$11.99M | -$45.29M | -$64.2M | -$93.62M | -$132.22M | -$64.09M | -$102.22M | -$92.09M | -$52.01M | — | — | — | — | — | — | — | — | — | — | |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | $116.66K | $2.04M | $1.12M | — | — | |
| $175.38K | — | — | — | — | — | — | — | — | — | — | — | — | $201.02K | $65.07K | $76.33K | $5730 | $140 | — | — | |
| $8.76M | $6M | $5.57M | $3.45M | $1.02M | $302K | $2.62M | $4.31M | $3.08M | $368K | $399K | $1.2M | $167.65K | $201.02K | $65.07K | -$342.66K | -$10.52M | -$1.2M | — | — | |
| — | -$6.12M | -$39.85M | -$61.2M | -$93.09M | -$132.39M | -$62.15M | -$98.41M | -$89.65M | -$51.86M | -$44.88M | -$28.45M | -$23.79M | — | — | — | — | — | — | — | |
| — | $0 | $330K | $33K | $0 | -$2.53M | $0 | -$774K | $1.1M | -$9.05M | -$618K | $0 | $0 | — | — | — | — | — | — | — | |
| -$42K | -$6.12M | -$40.18M | -$61.23M | -$93.09M | -$129.86M | -$62.15M | -$97.63M | -$90.75M | -$42.81M | -$44.26M | -$28.45M | -$23.79M | -$19.4M | -$24.79M | -$34.34M | -$15.29M | -$4.54M | -$8.79M | -$4.57M | |
| — | -8.47% | -140.87% | -854.78% | — | -2076.35% | -78.57% | -611.63% | -613.02% | -474.65% | — | — | — | — | — | — | — | — | — | — | |
| -$386K | -$5.95M | -$40.31M | -$60.51M | -$93.48M | -$130M | -$62.22M | -$97.49M | -$90.71M | -$42.6M | -$44.04M | -$29.28M | -$23.79M | — | — | — | — | — | — | — | |
| USD/shares | $1.21 | -$0.55 | -$6.69 | -$13.38 | -$23.08 | -$36.00 | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| USD/shares | $1.21 | -$0.55 | -$6.69 | -$13.38 | -$23.08 | -$36.00 | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| shares | — | 11.21M | 6M | 4.58M | 4.03M | 3.61M | 2.95M | 2.19M | 1.9M | 1.48M | 1.44M | 1.31M | 583.24K | 323.22K | 1.06M | 801.16K | 51.66K | — | — | — |
| shares | — | 11.21M | 6M | 4.58M | 4.03M | 3.61M | 2.95M | 2.19M | 1.9M | 1.48M | 1.44M | 1.31M | 583.24K | 323.22K | 1.06M | 801.16K | 51.66K | — | — | — |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Debt Profile
Annual debt figures are established from 10-K filings and updated by subsequent 10-Q and 8-K disclosures. Instrument balances are not summed into a company total unless the filing itself reports that total.
Debt data is being processed. Please check back later.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
Peer median 6.45×
EV/EBIT
—
Peer median 10.93×
P/E (TTM)
—
Peer median 12.78×
Peer medians compare against the 312 similar-size Biotechnology companies (of 536 listed).
Key facts
CIK
1426800
CUSIP
045396207
13F (30d)
50 filings
50 filers
Visit website
Investor relations